NARA Discovery
NARA Subscribed Scholarly Literature Discovery
Boolean search: climate AND coral · microplastic OR nanoplastic · plastic NOT freshwater · "marine heatwave"
Advanced Search
Topic searches article titles and abstracts. Starts a new search; publisher and year refine it.
Searches article titles and abstracts.
Accepts bare DOI, doi: prefix, or a doi.org URL.
Complete publisher name. Publisher imprints are grouped under their main publisher where applicable.
Exact match by full journal title or ISSN.
–
Refine Results Clear Filters
Collection
NARA Subscribed2
Publisher
Springer Nature2
Journal
Inflammopharmacology2
Publication Year
20231
20201
Graham Pennick results 2 · Newest (Page 1/1, per page 25)
Export CSV Export RIS Export current results · up to 5,000 records
Author: Graham Pennick ×Clear All Filters
Search Results
Ibuprofen, other NSAIDs and COVID-19: a narrative reviewNARA Subscribed
Inflammopharmacology · 2023 · Vol. 31 · Issue 5 · Springer
William Laughey; Imran Lodhi; Graham Pennick; Lucinda Smart; Olutoba Sanni; Suneet Sandhu; Bruce Charlesworth
At the start of the coronavirus disease 2019 (COVID-19) pandemic (March 2020), there was speculation that non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, used to manage some of the symptoms of COVID-19, could increase the susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and negatively impact clinical outcomes. In the absence of any robust mechanistic and clinical eviden...
View Details View Full Text
A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and realityNARA Subscribed
Inflammopharmacology · 2020 · Vol. 28 · Issue 5 · Springer
Lucinda Smart; Neil Fawkes; Paul Goggin; Graham Pennick; K. D. Rainsford; Bruce Charlesworth; Neil Shah
The coronavirus disease 19 (COVID-19) pandemic is currently the most acute healthcare challenge in the world. Despite growing knowledge of the nature of Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2), treatment options are still poorly defined. The safety of non-steroidal anti-inflammatory drugs (NSAIDs), specifically ibuprofen, has been openly questioned without any supporting evidence or clarity over dose, dura...
View Details View Full Text